Skip to content
Bomb Report – Lifestyle
Author:
Mezzion Pharmaceuticals, Inc
FUEL FALD Study Published in Pediatric Cardiology
July 16, 2026
Mezzion Secures Strategic Financing to Support Advancement of Global Phase 3 FUEL-2 Trial in Fontan Patients
May 14, 2026
Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD
May 7, 2026